Analysis Life Sciences Thank You What We Expect the FDA to do in July 2023
Agency IQ
JUNE 29, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. OIG claims a review will be complete in 2024. The final rule will amend the administrative destruction provisions in 21 CFR 1.94
Let's personalize your content